DADE BEHRING INC
8-K, 1999-05-24
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CLARITI TELECOMMUNICATIONS INTERNATIONAL LTD, 8-K, 1999-05-24
Next: IMAGE SENSING SYSTEMS INC, SC 13D, 1999-05-24



                   SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C.  20549
                      ___________________________




                                FORM 8-K

                             CURRENT REPORT




                 Pursuant to Section 13 or 15(d) of the
                    Securities Exchange Act of 1934



     Date of Report (Date of earliest event reported) May 21, 1999




                           DADE BEHRING INC.


         (Exact name of registrant as specified in its charter)


          Delaware                333-13523          36-3949533
(State or other jurisdiction     (Commission        (IRS Employer
      of incorporation)          File Number)    Identification No.)

   1717 Deerfield Road, Deerfield, Illinois          60015-0778
   (Address of principal executive offices)          (Zip Code)


Item 5  Other Events

        The Registrant is a wholly-owned subsidiary of Dade Behring
        Holdings, Inc. which announced that, as a result of its
        previously reported share repurchase program, Hoechst AG's
        economic ownership would increase to approximately 50% while the
        non-Hoechst AG shareholders will continue to hold voting
        control.  Approximately $400 million of its outstanding stock
        will be repurchased from its non-Hoechst AG shareholders.

        Also, the Registrant announced a proposed new senior bank credit
        facility which will replace its current senior bank credit
        facility and finance the share repurchase program of Dade
        Behring Holdings, Inc.

 Item 7 Financial Statements, Pro Forma Financial Information and
        Exhibits

        (c)  Exhibits

             99.1  Press Release related to the Dade Behring Holdings,
                   Inc. share repurchase program and the Dade Behring Inc.
                   proposed new senior bank credit facility.
<PAGE>
                               SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the Registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.

                              Dade Behring Inc.
                              (Registrant)


                              By:/s/
                              Name:   Glenn R. Richter
                              Title:  Senior Vice President and
                                      Chief Financial Officer
                                      (Duly Authorized Officer of
                                      Registrant)
Dated:  May 24, 1999



N E W S   R E L E A S E
                                                 DADE BEHRING
DADE BEHRING INC.
1717 Deerfield Road
P.O. Box 778
Deerfield, IL  60015-0778
847.267.5300

For Immediate Release

Contact:  Fred Nachman for Dade Behring, 312-832-9300 x202
        Joe Grillo for Bain Capital, 617-951-0000


 Dade Behring Announces Ownership Position of Hoechst AG Will Increase
to Approximately 50 Percent After Completion of Share Repurchase Program

        Voting Control to Remain with Current Shareholder Group


     DEERFIELD, Ill. (May 21, 1999) - Dade Behring, a leading global

manufacturer and marketer of products and systems serving clinical

diagnostics, today announced that following the completion of a share

repurchase program announced on May 3, 1999, Hoechst AG will increase

its economic ownership in the company to approximately 50 percent.  The

non-Hoechst AG shareholders of Dade Behring - Bain Capital, Goldman

Sachs & Co. and company management - will continue to hold voting

control of the company.


     Hoechst AG, headquartered in Frankfurt, Germany, currently owns a

32.5 percent share of Dade Behring.  Under the share repurchase program,

Dade Behring will repurchase approximately $400 million of its

outstanding stock from its non-Hoechst AG shareholders and retire these

shares.


     Also, Dade Behring Inc. announced that it has appointed Bankers

Trust Company as Administrative Agent and Goldman Sachs Credit Partners

L.P. as Syndication Agent for a new senior bank credit facility.  The
<PAGE>
bank credit facility will replace the company's current senior bank

credit facility and finance the share repurchase program.  The company

said it expects the refinancing to close within the next 60 days.


     With 1998 revenues of approximately $1.3 billion, Dade Behring is

among the largest clinical diagnostics companies worldwide and provides

the broadest available offering of products and systems for diagnostics

testing.  Dade Behring is headquartered in Deerfield, Illinois, has

operations in 39 countries and works through distributors in other

regions.

                                 # # #



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission